Keyword: Rentschler Biopharma

News

Rentschler in Collaboration to Improve AAV-Manufacturing for Gene Therapies

25.08.2023 -

German CDMO Rentschler Biopharma is collaborating with the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization...

News

Rentschler Appoints Mark Caswell as Vice President, US Facility Site Head

18.08.2022 -

Rentschler Biopharma has appointed Mark Caswell as Vice President and Site Head. He joined Rentschler in July 2022 and is managing all operations at the company’s US...

News

CureVac Cancels two Vaccine Manufacture Deals

15.09.2021 -

German biotech CureVac has canceled manufacturing contracts with two prospective partners for its Covid-19 vaccine CVnCoV while retaining others. The company said on Sept...

News

Rentschler Invests in UK Cell and Gene Therapy Site

16.02.2021 -

German CDMO Rentschler Biopharma is to establish manufacturing capacity for advanced therapy medicinal products (ATMPs), including Adeno-associated virus (AAV) vectors...

Services

Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler Biopharma SE -

Rentschler Biopharma offers bioprocess development and cGMP manufacturing for high-quality biopharmaceuticals. The company’s strength lies in its extensive experience...

News

Rentschler to Support BioNTech-Pfizer Vaccine

09.10.2020 -

German CDMO Rentschler Biopharma has reached agreement with Pfizer and BioNTech to handle the downstream purification process for the partnership’s mRNA-based COVID-19...

Strategy & Management

Facing Strong Headwinds

14.09.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

Strategy & Management

Outsourcing Services: from Gene to Patient

19.02.2020 -

Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient...